Physician profile
Gail M Herzig
NPI 1689608440
$3,041.81
in general payments reported to CMS, 2019-2025
16 companies · $720 in 2025
The $720 reported for 2025 was more than what a typical Gastroenterology (Internal Medicine) provider received nationally (typical 2025 total: $636).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $56.36 · 2020: $39.74 · 2021: $99.35 · 2022: $344 · 2023: $821 · 2024: $961 · 2025: $720.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,502.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,502.05 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,250.00 | 2020-2025 | |
| Gilead Sciences, INC. | $543.47 | 2019-2025 | |
| Pfizer INC. | $338.11 | 2023-2025 | |
| Janssen Biotech, INC. | $208.04 | 2021-2024 | Tremfya, Stelara |
| Janssen Scientific Affairs, LLC | $143.98 | 2024 | Tremfya |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $119.21 | 2021-2023 | Xifaxan |
| Takeda Pharmaceuticals U.S.A., INC. | $114.19 | 2021-2023 | Entyvio, Gattex |
| Fresenius Kabi USA, LLC | $71.41 | 2023-2024 | Idacio |
| Stryker Corporation | $68.59 | 2024 | Neptune |
| Regeneron Healthcare Solutions, INC. | $56.24 | 2025 | Dupixent |
| Boehringer Ingelheim Pharmaceuticals, INC. | $29.22 | 2023 | Cyltezo |
| Fujifilm Healthcare Americas Corporation | $25.61 | 2023 | Fujifilm |
| Micro-Tech Endoscopy USA, INC. | $21.48 | 2025 | Lockado |
| Celgene Corporation | $20.15 | 2023 | Zeposia |
| Ferring Pharmaceuticals INC. | $17.20 | 2019 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $14.91 | 2025 | Gi Genius |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gail Herzig listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.